Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis

被引:112
作者
Miura, SI [1 ]
Karnik, SS [1 ]
机构
[1] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol NB50, Cleveland, OH 44195 USA
关键词
angiotensin II; apoptosis; AT(2) receptor; p38; vascular smooth muscle cells;
D O I
10.1093/emboj/19.15.4026
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Conventional models of ligand-receptor regulation predict that agonists enhance the tone of signals generated by the receptor in the absence of ligand. Contrary to this paradigm, stimulation of the type 2 (AT(2)) receptor by angiotensin II (Ang II) is not required for induction of apoptosis but the level of receptor protein expression is critical. We compared Ang II-dependent and -independent AT(2) receptor signals involved in regulating apoptosis of cultured fibroblasts, epithelial cells and vascular smooth muscle cells. We found that induction of apoptosis--blocked by pharmacological inhibition of p38 mitogen-activated protein kinase and caspase 3--is a constitutive function of the AT(2) receptor. Biochemical and genetic studies suggest that the level of AT(2) receptor expression is critical for physiological ontogenesis and its expression is restricted postnatally, coinciding with cessation of developmental apoptosis, Re-expression of the AT(2) receptor in remodeling tissues in the adult is linked to control of tissue growth and regeneration. Therefore, we propose that overexpression of the AT(2) receptor itself is a signal for apoptosis that does not require the renin-angiotensin system hormone Ang II.
引用
收藏
页码:4026 / 4035
页数:10
相关论文
共 37 条
  • [1] Death receptors: Signaling and modulation
    Ashkenazi, A
    Dixit, VM
    [J]. SCIENCE, 1998, 281 (5381) : 1305 - 1308
  • [2] BOTTGER M, 1991, OXIDOREDUCTION PLASM, V2, P207
  • [3] AGONISTIC AND ANTAGONISTIC PROPERTIES OF ANGIOTENSIN ANALOGS AT THE AT2-RECEPTOR IN PC12W CELLS
    BRECHLER, V
    JONES, PW
    LEVENS, NR
    DEGASPARO, M
    BOTTARI, SP
    [J]. REGULATORY PEPTIDES, 1993, 44 (02) : 207 - 213
  • [4] RECEPTOR STATE AND LIGAND EFFICACY
    CHIDIAC, P
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (03) : 83 - 84
  • [5] Dimmeler S, 1997, CIRC RES, V81, P970
  • [6] DUDLEY DT, 1991, MOL PHARMACOL, V40, P360
  • [7] ANGIOTENSIN-II SIGNAL-TRANSDUCTION AND THE MITOGEN-ACTIVATED PROTEIN-KINASE PATHWAY
    DUFF, JL
    MARRERO, MB
    PAXTON, WG
    SCHIEFFER, B
    BERNSTEIN, KE
    BERK, BC
    [J]. CARDIOVASCULAR RESEARCH, 1995, 30 (04) : 511 - 517
  • [8] Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production
    Eliopoulos, AG
    Gallagher, NJ
    Blake, SMS
    Dawson, CW
    Young, LS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (23) : 16085 - 16096
  • [9] G protein-coupled receptors - II. Mechanism of agonist activation
    Gether, U
    Kobilka, BK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (29) : 17979 - 17982
  • [10] Growth-dependent induction of angiotensin II type 2 receptor in rat mesangial cells
    Goto, M
    Mukoyama, M
    Suga, S
    Matsumoto, T
    Nakagawa, M
    Ishibashi, R
    Kasahara, M
    Sugawara, A
    Tanaka, I
    Nakao, K
    [J]. HYPERTENSION, 1997, 30 (03) : 358 - 362